Bullous Pemphigoid
📧 Sign up to get email alerts when something new happens for Bullous Pemphigoid.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid [Phase 3]
Phase 3 clinical trial evaluating topical steroids alone or with methotrexate for bullous pemphigoid has completed. The record notes the stu…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid [Phase 3]
A Phase 3 trial evaluating the efficacy and tolerability of Rituximab (MabThera) in Bullous Pemphigoid has completed.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) [Phase 1]
Phase 1b long-term extension trial of RAY121 in multiple immunological diseases is currently enrolling by invitation, expanding early-phase …
-
CLINICAL_TRIALS other · 2026-04-02Clinical Trial Update: Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) [Phase 1]
Chugai Pharmaceutical’s RAY121 is being studied in a Phase 1b trial (RAINBOW) across several immunological diseases, and the study is curren…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Autoimmune Blistering Diseases Study
This clinical trial update from the University of Pennsylvania indicates the study is currently recruiting for autoimmune blistering disease…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody [Phase 2]
Phase 2 clinical trial evaluating avdoralimab (IPH5401), an anti-C5aR1 monoclonal antibody, for bullous pemphigoid has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the efficacy and safety of dupilumab in adult patients with bullous pemphigoid has completed and results have b…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid [Phase 3]
A Phase 3 study evaluating the long-term safety, tolerability, and efficacy of Efgartigimod PH20 SC in adults with bullous pemphigoid has be…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid [Phase 4]
Phase 4 clinical trial evaluating fluid retention associated with a superpotent topical corticosteroid in bullous pemphigoid has completed. …
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid [Phase 2]
Phase 2 trial evaluating Bertilimumab in bullous pemphigoid. Results addressing safety, efficacy and pharmacodynamic effects were posted.
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid [Phase 2, Phase 3]
A Phase 2/3 study assessing subcutaneous efgartigimod with PH20 for Bullous Pemphigoid has completed enrollment and posted results.
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid [Phase 3]
A Phase 3 clinical trial evaluating Stapokibart Injection for moderate to severe Bullous Pemphigoid is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Prevalence of Sleep Disturbances in Bullous Pemphigoid Patients.
A completed clinical trial update assessing the prevalence of sleep disturbances in patients with Bullous Pemphigoid.
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid [Phase 4]
Phase 4 trial comparing add-on dapsone versus add-on methotrexate for efficacy and safety in bullous pemphigoid has completed.
-
CLINICAL_TRIALS approval · 2025-07-03Clinical Trial Update: Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid
Dupilumab has been approved for marketing to treat Bullous Pemphigoid in adults. This expands its approved indications to an autoimmune blis…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects [Phase 2]
Clinical trial update indicating completion of a Phase 2 study of rVA576 in adults with mild to moderate Bullous Pemphigoid.
-
CLINICAL_TRIALS withdrawal · 2025-04-09Clinical Trial Update: Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) [Phase 3]
Phase 3 trial of nomacopan for bullous pemphigoid in adults receiving adjunct corticosteroids was withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid. [Phase 3]
A Phase 3 trial evaluating benralizumab for Bullous Pemphigoid was terminated and results were posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: JAK Inhibitors' Efficacy in Bullous Pemphigoid
A completed clinical trial evaluating the efficacy of Janus kinase inhibitors in treating bullous pemphigoid has been updated.
-
CLINICAL_TRIALS withdrawal · 2024-07-03Clinical Trial Update: Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid [Phase 3]
Phase 3 study evaluating rituximab in combination with omalizumab for bullous pemphigoid has been withdrawn.
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid [NA]
The clinical trial is investigating the IL-17–dependent inflammatory response in Bullous Pemphigoid and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid [Phase 2]
A Phase 2 trial of adjunctive AKST4290 for bullous pemphigoid was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Efficacy and Safety of Ustekinumab in Bullous Pemphigoid [Phase 2]
Phase 2 trial assessing efficacy and safety of ustekinumab in bullous pemphigoid has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid [Phase 4]
Phase 4 clinical trial investigating how dermocorticoids affect bone mineral density in patients with bullous pemphigoid, with osteoporosis …
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid [Phase 3]
Phase 3 trial update investigating ozonated olive oil for Pemphigus Vulgaris and Bullous Pemigoid; current status is unknown.